8-K: Parabolic Technologies Faces Nasdaq Delisting
Current Report (8-K)
Parabolic Technologies received a delisting notice from Nasdaq due to a sustained low stock bid price, despite recent reverse stock splits and an increase in authorized shares.
Summary
- Parabolic Technologies, Inc. received a notification from Nasdaq indicating non-compliance with the minimum bid price rule (below $1.00 for 30 consecutive days).
- The company is not eligible for a compliance period due to multiple reverse stock splits within the past two years, totaling a 1-for-2,000 ratio.
- Nasdaq has issued a Staff Delisting Determination, with trading suspension and delisting planned for November 5, 2026, unless an appeal is requested.
- The company plans to request a hearing before a Nasdaq Hearings Panel to present a plan for regaining compliance, including a recent 1-for-10 reverse stock split.
- A Certificate of Amendment to the company's Certificate of Incorporation was filed on October 30, 2026, to increase authorized shares to 850,000,000.
- This increase includes 750,000,000 shares of Class A common stock, 25,000,000 shares of Class B common stock, and 75,000,000 shares of preferred stock.
- Shareholders approved the authorized share increase, potential public offering issuance, and issuance of shares related to a convertible note and warrants.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as negative due to the company's non-compliance with Nasdaq's minimum bid price rule and the subsequent delisting determination, despite efforts like reverse stock splits and an authorized share increase.
Positives
- Shareholders approved the increase in authorized shares, providing potential flexibility for future financing or strategic initiatives.
- Shareholders also approved the potential issuance of shares in a financing and upon conversion/exercise of notes and warrants, indicating support for capital-raising efforts.
- The company is actively pursuing a hearing to appeal the delisting determination, demonstrating a commitment to remaining listed on Nasdaq.
Negatives
- The company is facing delisting from the Nasdaq Capital Market due to its stock's closing bid price being below $1.00 for 30 consecutive business days.
- Due to a history of reverse stock splits (cumulative 1-for-2,000 ratio), the company is ineligible for the standard 180-day compliance period.
- Trading suspension is scheduled for November 5, 2026, if no appeal is filed by November 3, 2026.
- The company's efforts, including multiple reverse stock splits (July 2025, May 2026, October 2026), have not resulted in sustained compliance with the bid price rule.
Risks
- The primary risk is the delisting from The Nasdaq Capital Market, which could significantly reduce liquidity and investor confidence.
- There is no assurance that the Nasdaq Hearings Panel will grant the company's request for continued listing or allow additional time to regain compliance.
- Failure to regain compliance with the bid price rule could lead to a loss of listing on Nasdaq, impacting the company's ability to access capital markets.
- The company's stock price performance indicates significant market concerns about its valuation and future prospects.
Future Outlook
The company's immediate future outlook is uncertain as it faces delisting from Nasdaq. Its ability to regain compliance with the bid price rule and remain listed is contingent on a successful appeal to the Nasdaq Hearings Panel. The increase in authorized shares provides potential future capital raising flexibility, but this is secondary to the immediate listing concerns.
Management Comments
- The Company intends to timely request a hearing before the Panel pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series.
- In connection with the hearing, the Company intends to present a plan to regain compliance with the Bid Price Rule, including the 1-for-10 reverse stock split effected on October 27, 2026.
- There can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to regain compliance with the Bid Price Rule within any additional period of time that may be granted by the Panel.
Industry Context
StockSavvy.ai notes that Nasdaq's bid price rule is a common compliance hurdle for companies experiencing significant stock price declines. The company's history of reverse stock splits, while intended to boost share price, has disqualified it from standard grace periods, highlighting a critical challenge in regaining compliance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Increase in authorized shares from 350,000,000 to 850,000,000. | 2026-10-30 | Provides greater flexibility for future capital raises and strategic transactions, but does not address the immediate delisting threat. |
Legal Proceedings
- The company is subject to a Staff Delisting Determination by Nasdaq, which could lead to its securities being removed from listing and registration on Nasdaq.
Stakeholder Impact
- Shareholders: Potential delisting significantly impacts liquidity and may lead to a decrease in share value. However, shareholder approval of share increase and potential financing offers some future upside potential.
- Creditors: Delisting could impact the company's ability to service debt if it cannot access capital markets.
- Employees: Uncertainty surrounding the company's listing status may affect employee morale and retention.
Next Steps
- The company will request a hearing before the Nasdaq Hearings Panel.
- The company will present a plan to regain compliance with the Bid Price Rule at the hearing.
- Trading suspension and delisting will occur on November 5, 2026, if no appeal is requested by November 3, 2026.
- The company will await the Panel's decision regarding continued listing.
Key Dates
| Date | Description |
|---|---|
| 2025-07-08 | Effective date of a 1-for-10 reverse stock split. |
| 2026-05-08 | Effective date of a 1-for-20 reverse stock split. |
| 2026-09-15 | Start date of the 30-day period where the closing bid price was below $1.00. |
| 2026-10-26 | End date of the 30-day period where the closing bid price was below $1.00. |
| 2026-10-27 | Date the company received the Notice of Delisting from Nasdaq. |
| 2026-10-27 | Effective date of a 1-for-10 reverse stock split. |
| 2026-10-30 | Filing date of the Certificate of Amendment to increase authorized shares. |
| 2026-11-03 | Deadline to request a hearing to appeal the delisting determination. |
| 2026-11-05 | Scheduled date for trading suspension and filing of Form 25-NSE if no appeal is filed. |
Recommendation
sellThe company is facing imminent delisting from Nasdaq due to sustained non-compliance with the minimum bid price rule, a situation exacerbated by its ineligibility for a compliance period due to prior reverse stock splits. While the company is pursuing an appeal, the outlook is highly uncertain and the risk of delisting is substantial, which typically leads to a significant decline in stock value and liquidity.
Keywords
Nasdaq delisting, bid price rule, reverse stock split, authorized shares, capital increase, corporate governance, stockholder meeting, compliance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.